LPL Financial LLC Acquires 15,746 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

LPL Financial LLC increased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 12.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 141,604 shares of the medical device company's stock after acquiring an additional 15,746 shares during the quarter. LPL Financial LLC owned about 0.07% of Cooper Companies worth $13,018,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also bought and sold shares of COO. Fulton Bank N.A. grew its holdings in shares of Cooper Companies by 3.0% during the fourth quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company's stock valued at $342,000 after buying an additional 109 shares during the last quarter. Torray Investment Partners LLC boosted its stake in Cooper Companies by 0.8% during the 4th quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company's stock valued at $1,488,000 after purchasing an additional 132 shares during the last quarter. Mather Group LLC. increased its holdings in shares of Cooper Companies by 7.4% in the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company's stock worth $177,000 after purchasing an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB raised its stake in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company's stock worth $93,000 after purchasing an additional 136 shares during the last quarter. Finally, Greenleaf Trust lifted its holdings in shares of Cooper Companies by 5.0% during the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company's stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. Institutional investors own 24.39% of the company's stock.

Remove Ads

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. StockNews.com lowered Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Piper Sandler restated an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. JPMorgan Chase & Co. dropped their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a report on Friday, March 7th. Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, BNP Paribas upgraded Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Stock Performance

Cooper Companies stock traded down $0.46 during trading on Monday, reaching $73.31. The company had a trading volume of 2,131,231 shares, compared to its average volume of 1,371,951. The firm has a market capitalization of $14.66 billion, a price-to-earnings ratio of 37.60, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm's 50-day simple moving average is $87.24 and its 200 day simple moving average is $95.87. The Cooper Companies, Inc. has a 52 week low of $70.77 and a 52 week high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.